Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Intermittently Scanned Continuous Glucose Monitoring for Type 1 Diabetes

Open access

Abstract

BACKGROUND: In persons with type 1 diabetes and high glycated hemoglobin levels, the benefits of intermittently scanned continuous glucose monitoring with optional alarms for high and low blood glucose levels are uncertain. METHODS: In a parallel-group, multicenter, randomized, controlled trial involving participants with type 1 diabetes and glycated hemoglobin levels between 7.5% and 11.0%, we investigated the efficacy of intermittently scanned continuous glucose monitoring as compared with participant monitoring of blood glucose levels with fingerstick testing. The primary outcome was the glycated hemoglobin level at 24 weeks, analyzed according to the intention-to-treat principle. Key secondary outcomes included sensor data, participant-reported outcome measures, and safety. RESULTS: A total of 156 participants were randomly assigned, in a 1:1 ratio, to undergo intermittently scanned continuous glucose monitoring (the intervention group, 78 participants) or to monitor their own blood glucose levels with fingerstick testing (the usual-care group, 78 participants). At baseline, the mean (±SD) age of the participants was 44±15 years, and the mean duration of diabetes was 21±13 years; 44% of the participants were women. The mean baseline glycated hemoglobin level was 8.7±0.9% in the intervention group and 8.5±0.8% in the usual-care group; these levels decreased to 7.9±0.8% and 8.3±0.9%, respectively, at 24 weeks (adjusted mean between-group difference, -0.5 percentage points; 95% confidence interval [CI], -0.7 to -0.3; P<0.001). The time per day that the glucose level was in the target range was 9.0 percentage points (95% CI, 4.7 to 13.3) higher or 130 minutes (95% CI, 68 to 192) longer in the intervention group than in the usual-care group, and the time spent in a hypoglycemic state (blood glucose level, <70 mg per deciliter [<3.9 mmol per liter]) was 3.0 percentage points (95% CI, 1.4 to 4.5) lower or 43 minutes (95% CI, 20 to 65) shorter in the intervention group. Two participants in the usual-care group had an episode of severe hypoglycemia, and 1 participant in the intervention group had a skin reaction to the sensor. CONCLUSIONS: Among participants with type 1 diabetes and high glycated hemoglobin levels, the use of intermittently scanned continuous glucose monitoring with optional alarms for high and low blood glucose levels resulted in significantly lower glycated hemoglobin levels than levels monitored by fingerstick testing. (Funded by Diabetes UK and others; FLASH-UK ClinicalTrials.gov number, NCT03815006.).

Overview

Integrity signals

Registry

Crossref · 10.1056/nejmoa2205650

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Citations

Cites

Show all 26 references

Cited by

See all 182

Metadata

Authors
Leelarathna, L., Evans, M. L., Neupane, S., Rayman, G., Lumley, S., Cranston, I., Narendran, P., Barnard-Kelly, K., Sutton, C. J., Elliott, R. A., Taxiarchi, V. P., Gkountouras, G., Burns, M., Mubita, W., Kanumilli, N., Camm, M., Thabit, H., & Wilmot, E. G.
Affiliations
  • University of Cambridge (GB)
  • University Hospitals Birmingham NHS Foundation Trust (GB)
  • From the Diabetes, Endocrinology, and Metabolism Centre, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre (L.L., W.M., N.K., M.C., H.T.), the Division of Diabetes, Endocrinology, and Gastroenterology, Faculty of Biology, Medicine, and Health (L.L., H.T.), and the Centre for Biostatistics (C.J.S., V.P.T.), the Manchester Centre for Health Economics (R.A.E., G.G.), and the Manchester Clinical Trials Unit (C.J.S., M.B.), Division of Population Health, Health Service Research and Primary Care, University of Manchester, Manchester, Wellcome Trust–Medical Research Council Institute of Metabolic Science, National Institute for Health and Care Research Cambridge Biomedical Research Centre, Cambridge University Hospitals and University of Cambridge, Cambridge (M.L.E.), Elsie Bertram Diabetes Centre, Norfolk (S.N.), Norwich University Hospitals NHS Foundation Trust, Norwich (S.N.), the Diabetes and Endocrine Centre, Ipswich Hospital, East Suffolk and N...
  • University of Nottingham (GB)
Venue
New England Journal of Medicine
Published
2022-10-20
Volume
387
Issue
16
Pages
1477-1487
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W4302023802
Cited by
174
References
26
Citations by year
2026: 23 · 2025: 45 · 2024: 49 · 2023: 49 · 2022: 7
FWCI
27.77
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Repository@Nottingham (University of Nottingham) (acceptedVersion, other-oa)
  • Repository@Nottingham (University of Nottingham) (submittedVersion, cc-by)
  • Research Explorer (The University of Manchester) (submittedVersion, other-oa)
Funders
Diabetes UK (18/0005836)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
intermittently scanned continuous glucose monitoring, type 1 diabetes, HbA1c, glycemic control, hypoglycemia, time in range, patient-reported outcomes, diabetes self-management, glycemic variability, HbA1c reduction, hypoglycemia risk reduction, severe hypoglycemia
MeSH terms
Adult, Blood Glucose, Diabetes Mellitus, Type 1, Female, Glycated Hemoglobin, Humans, Hypoglycemia, Hypoglycemic Agents, Insulin, Male, Middle Aged, Blood Glucose Self-Monitoring

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Intermittently Scanned Continuous Glucose Monitoring for Type 1 Diabetes. https://app.cochat.ai/papers/10.1056/nejmoa2205650
The paper
Leelarathna, L., Evans, M. L., Neupane, S., Rayman, G., Lumley, S., Cranston, I., Narendran, P., Barnard-Kelly, K., Sutton, C. J., Elliott, R. A., Taxiarchi, V. P., Gkountouras, G., Burns, M., Mubita, W., Kanumilli, N., Camm, M., Thabit, H., & Wilmot, E. G. (2022). Intermittently Scanned Continuous Glucose Monitoring for Type 1 Diabetes. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2205650

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.